# Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy

> **NCT00967629** · PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 20 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Sevelamer Carbonate
- **DRUG:** Calcium Carbonate

## Key facts

- **NCT ID:** NCT00967629
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967629, "Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00967629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*